Thermal ablation rollout and cost study for cervical pre-cancer
Part of Cancer, Women’s health & pregnancy clinical trials.
This study looks at how best to add a treatment called thermal ablation for cervical pre-cancer into regular clinic care, and how much it costs. It may help clinics deliver care more effectively and more affordably in the future.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be at a participating reproductive health clinic or role connected to it
- You must be a woman who is 25 to 60 years old seeking cervical cancer screening
- Your screening must show pre-cancer changes in the cervix
- You (or your clinic role) must be willing to give consent for research participation
- You cannot refuse to take part or to allow your study data to be collected
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests ways to improve cervical cancer screening for women ages 30–65. It may help catch cervical cancer early or prevent it entirely by finding precancerous changes.
This study looks at better ways to manage early precancerous changes in the cervix (called high-grade lesions) without surgery. It aims to find which approaches work best for women who have not been vaccinated against HPV.
This trial studies whether adding controlled heat (“hyperthermia”) to radiation therapy (or radiation with chemotherapy) can improve outcomes in advanced cervical cancer. It focuses on people who can safely receive intensive pelvic radiation and heat treatment.
This study tests two different approaches to treating early cervical changes in women living with HIV who tested positive for HPV (a virus that can cause cervical cancer). The goal is to see which approach works better and is easier to use in South Africa.
This study tests two different ways to treat early cervical changes caused by HPV in women living with HIV. It compares using one heating probe versus two heating probes to destroy abnormal cervical tissue, and measures which approach works better and is easier to use.
This trial tests a new way to quickly diagnose and treat cervical pre-cancer using a point-of-care device. It may help women who are HPV-positive avoid a separate treatment visit.
Hear when a new Cervical Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.